Orbimed Advisors, Director: Prelude Therapeutics PRLD Buy · Filed 23/05/24

Trade details

Type: Insider buy
Amount: $4,999,998.75
Shares · price: 869,565 sh · $5.75 a share
Held after: 10,119,756 sh
Stock: Prelude Therapeutics PRLD
Person: Orbimed AdvisorsDirector
Trade date: 23/05/22
Filed: 23/05/24
Days to filing: 2 days

7 insiders bought this week

Insiders buying this week: 7 insiders
Holding change: +9.4%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21

Orbimed Advisors, Director — bought $5M of Prelude Therapeutics PRLD · 869,565 sh @ $5.75 | Whalegun